Questions: Plasma Cell Differentiation and Antibody Secretion

Question 1

An experimental drug specifically blocks Blimp-1 expression in activated B cells. What would you most likely observe?

• A. B cells would proliferate faster and produce more antibodies due to loss of a repressor
• B. B cells would fail to differentiate into plasma cells and could not efficiently secrete antibodies
• C. B cells would become memory cells instead, conferring longer-lasting immunity
• D. B cells would undergo apoptosis because Blimp-1 is required for cell survival

Answer: (B)

Blimp-1 is the master transcription factor that drives plasma cell differentiation. It shuts down B cell identity genes (including Pax5) and upregulates the entire plasma cell program — immunoglobulin secretion, ER expansion, metabolic reprogramming. Without Blimp-1, activated B cells cannot complete the transition to plasma cells: they retain B cell identity markers, cannot massively upregulate antibody secretion, and fail to develop the extensive ER infrastructure required for high-rate protein synthesis. This demonstrates why transcriptional reprogramming, not just antigen stimulation, is required for effective humoral immunity.

Question 2

Why does a plasma cell expand its endoplasmic reticulum so dramatically compared to a resting B cell?

• A. The expanded ER stores the antibodies before they are needed, acting as a reservoir
• B. Secreted antibodies are synthesized on the rough ER, so a massive ER expansion is required to accommodate the biosynthetic load of hundreds to thousands of antibodies per second
• C. The ER expands to sequester calcium away from the cytoplasm during the immune response
• D. The enlarged ER provides additional membrane for the increased number of surface immunoglobulin molecules

Answer: (B)

All secreted proteins, including antibodies, are synthesized on ribosomes attached to the rough ER, then processed through the Golgi and exported via secretory vesicles. A plasma cell secreting ~2,000 IgG molecules per second requires an enormous biosynthetic capacity. This is met by massively expanding the rough ER — electron microscopy shows plasma cells packed with parallel ER stacks. The ER stress from this volume of protein production also constitutively activates the unfolded protein response (UPR). The ER expansion is a direct functional consequence of the secretory demand, not a coincidence.

Question 3

Plasma cells are highly proliferative cells that continue dividing to maintain and increase antibody output during an immune response.

• T. True
• F. False

Answer: False

This is a fundamental misconception about plasma cell biology. Plasma cells are terminally differentiated and post-mitotic — they permanently exit the cell cycle as part of the differentiation process driven by Blimp-1. They will never divide again. Antibody output is maintained by the existing population of plasma cells secreting at high rates and, for sustained responses, by the stable long-lived plasma cell population in the bone marrow. Early in an immune response, short-lived plasmablasts retain some proliferative capacity, but fully differentiated plasma cells do not. Conflating proliferation with secretory output is a common error.

Question 4

Long-lived plasma cells residing in the bone marrow depend on survival signals from the local stromal microenvironment to persist for years after initial immunization.

• T. True
• F. False

Answer: True

Long-lived plasma cells are not intrinsically immortal — their longevity depends on occupying survival niches in the bone marrow where stromal cells provide essential cytokines (APRIL, BAFF, IL-6) and cell-cell contact signals. Competition for these limited niches shapes the long-term antibody repertoire: new responses can displace old plasma cells from their niches, reducing antibody titers against old antigens. This niche-dependence explains why bone marrow plasma cell populations are dynamic and why some vaccines require boosters to maintain protective antibody levels.

Question 5

A patient's serum contains measurable antibodies against a measles antigen 35 years after childhood vaccination, with no subsequent exposure or re-vaccination. What cell type is responsible for maintaining these antibody levels, and where does it reside?

Model answer: Long-lived plasma cells, residing in survival niches in the bone marrow, are responsible. These cells differentiated during the original immune response (particularly through germinal center reactions), migrated to the bone marrow, and have persisted ever since, continuously secreting antibody without further antigen stimulation. Their survival depends on signals from bone marrow stromal cells (including APRIL, BAFF, and IL-6), not on ongoing immune activation. This is the cellular basis of long-term humoral immunity and the mechanism by which vaccination confers protection decades later.

This distinguishes long-lived plasma cells from memory B cells, which are the other long-lived outcome of germinal center reactions. Memory B cells are quiescent — they don't secrete antibody until re-stimulated by antigen. Long-lived plasma cells are constitutively secretory. Sustained serum antibody levels (as in this scenario) reflect plasma cell activity; rapid secondary responses reflect memory B cell reactivation. Both are needed for durable vaccine protection.